Journal of the American College of Cardiology
Targeted Assessment in High-Risk Patients With Diabetes to Identify Undiagnosed Heart Failure (TARTAN-HF)
By Daniel Taylor‐Sweet, Mark Colquhoun Petrie, Gemma McKinley, Kieran F. Docherty
Show 25 more authors
Liane M. McGlynn, John Jarvie, Jack D. Beazer, Elaine Butler, Ellen MacDonald, Paul I. Welsh, Michelle Martinson, Katriona J.M. Brooksbank, Anna L Barnett, John Kerr, Colin J. Petrie, Robin A.P. Weir, Sasha T. Gold, Lesley M. L. Hall, Brian Kennon, Andrea Llano, Gerard McKay, Maroria Oroko, Malbinder Fagura, Elmas Malvolti, Naveed A. Sattar, Ross T. Campbell, Alex McConnachie, John J.V. McMurray, Carolyn S.P. Lam,Randomised trial in 706 peopleInterventions
Multicentre, registered NCT05705869, declared ties to: AstraZeneca, Roche Diagnostics, Boehringer Ingelheim and 79 more
- Nt-probnp-based screening
- Diabetes mellitus
- Heart failure
- Heart failure with preserved ejection fraction
- KCCQ-12
- Humans
The paper
Daniel Taylor‐Sweet, Mark Colquhoun Petrie, Gemma McKinley, Kieran F. Docherty
Show 25 more authors
Liane M. McGlynn, John Jarvie, Jack D. Beazer, Elaine Butler, Ellen MacDonald, Paul I. Welsh, Michelle Martinson, Katriona J.M. Brooksbank, Anna L Barnett, John Kerr, Colin J. Petrie, Robin A.P. Weir, Sasha T. Gold, Lesley M. L. Hall, Brian Kennon, Andrea Llano, Gerard McKay, Maroria Oroko, Malbinder Fagura, Elmas Malvolti, Naveed A. Sattar, Ross T. Campbell, Alex McConnachie, John J.V. McMurray, Carolyn S.P. Lam,University of Glasgow
Journal of the American College of Cardiology, 11 Aug 2026
